Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab170576 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Rovalpituzumab (anti-DLL3)
- Antibody type
- Recombinant
- Description
- Rovalpituzumab (anti-DLL3) is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab (anti-DLL3) can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab (anti-DLL3) has activity against small cell lung cancer (SCLC).Purity_>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Rovalpituzumab (anti-DLL3) (Ab170576) - ELISA Immobilized human-DLL3-ECD-His at 2 μg/mL can bind Rovalpituzumab (anti-DLL3) (Ab170576) with the EC₅₀ of 21.71 ng/mL.
